| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.006 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.44 | 0.007 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |